Immunological and Molecular Evaluation of IL-5 in Asthma Patients

dc.contributor.authorBaraa Jawad Kadhim
dc.contributor.authorAssist. Prof. Mohammad Reza Khakzad
dc.contributor.authorAssist. Prof. Jenna Khayat Zadeh
dc.date.accessioned2026-01-01T10:18:00Z
dc.date.issued2023-02-11
dc.description.abstractAsthma cause airway obstruction and are associated with chronic airway inflammation. Interleukin -5 is mainly produced by Th2 cells, innate lymphoid cells group 2 (ILC2), mast cells, natural killer T cells (NKT), and eosinophils themselves. Material and Method: A case-control study and the implementation steps are divided into 3 main parts, include: Patient selection and sampling, examining the intensity of gene expression. Result: The present study show that the expression of IL-5 gene has increased significantly in asthma. Regarding the intensity of IL-5 gene expression in the patient and control groups, a significant difference can be observed between the two groups in terms of gene expression intensity (PValue=0.0001). Conclusion: The results of the present study show that IL-5 gene expression has been significantly changed in asthma. In terms of the intensity of IL-5 gene expression in the patient and control groups, a significant difference is observed between the two groups (P-Value=0.0001), also the experiment and analysis of the obtained ROC curve shows that a significant change in IL-5 in Asthma.
dc.formatapplication/pdf
dc.identifier.urihttps://zienjournals.com/index.php/tjms/article/view/3352
dc.identifier.uri10.62480/tjms.2023.vol17.pp39-45
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/59549
dc.language.isoeng
dc.publisherZien Journals
dc.relationhttps://zienjournals.com/index.php/tjms/article/view/3352/2785
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceTexas Journal of Medical Science; Vol. 17 (2023): TJMS; 39-45
dc.source2770-2936
dc.subjectAsthma
dc.subjectChronic Obstructive Pulmonary Disease
dc.subjectCOPD
dc.titleImmunological and Molecular Evaluation of IL-5 in Asthma Patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
kadhim_2023_immunological_and_molecular_evaluation_o.pdf
item.page.filesection.size
270.78 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections